Literature DB >> 24252662

Eyeballing cholesterol efflux and macrophage function in disease pathogenesis.

Abdoulaye Sene1, Rajendra S Apte2.   

Abstract

Disorders of lipid metabolism are strongly associated with cardiovascular disease. Recently, there has been significant focus on how tissues process lipid deposits. Impaired cholesterol efflux has been shown to be crucial in mediating lipid deposition in atherosclerosis. The inability of macrophages to effectively efflux cholesterol from tissues initiates inflammation, plaque neovascularization, and subsequent rupture. Recent studies suggest that inability to effectively efflux cholesterol from tissues may have global implications far beyond atherosclerosis, extending to the pathophysiology of unrelated diseases. We examine the unifying mechanisms by which impaired cholesterol efflux facilitates tissue-specific inflammation and disease progression in age-related macular degeneration (AMD), a blinding eye disease, and in atherosclerosis, a disease associated with significant cardiovascular morbidity.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMD; atherosclerosis; cholesterol efflux; lipids; macrophage

Mesh:

Substances:

Year:  2013        PMID: 24252662      PMCID: PMC3943676          DOI: 10.1016/j.tem.2013.10.007

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  80 in total

1.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration.

Authors:  Yi Yu; Robyn Reynolds; Jesen Fagerness; Bernard Rosner; Mark J Daly; Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

2.  Distribution of macrophage polarization markers in human atherosclerosis.

Authors:  J Lauran Stöger; Marion J J Gijbels; Saskia van der Velden; Marco Manca; Chris M van der Loos; Erik A L Biessen; Mat J A P Daemen; Esther Lutgens; Menno P J de Winther
Journal:  Atherosclerosis       Date:  2012-09-26       Impact factor: 5.162

3.  Decreased atherosclerosis in low-density lipoprotein receptor knockout mice transplanted with Abcg1-/- bone marrow.

Authors:  Mollie Ranalletta; Nan Wang; Seongah Han; Laurent Yvan-Charvet; Carrie Welch; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-17       Impact factor: 8.311

Review 4.  High-density lipoprotein--the clinical implications of recent studies.

Authors:  D J Gordon; B M Rifkind
Journal:  N Engl J Med       Date:  1989-11-09       Impact factor: 91.245

5.  Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrow.

Authors:  Angel Baldán; Liming Pei; Richard Lee; Paul Tarr; Rajendra K Tangirala; Michael M Weinstein; Joy Frank; Andrew C Li; Peter Tontonoz; Peter A Edwards
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-03       Impact factor: 8.311

6.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

7.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouse.

Authors:  Elaine M Quinet; Michael D Basso; Anita R Halpern; David W Yates; Robert J Steffan; Valerie Clerin; Christine Resmini; James C Keith; Thomas J Berrodin; Irene Feingold; Wenyan Zhong; Helen B Hartman; Mark J Evans; Stephen J Gardell; Elizabeth DiBlasio-Smith; William M Mounts; Edward R LaVallie; Jay Wrobel; Ponnal Nambi; George P Vlasuk
Journal:  J Lipid Res       Date:  2009-03-24       Impact factor: 5.922

9.  Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo.

Authors:  Xun Wang; Heidi L Collins; Mollie Ranalletta; Ilia V Fuki; Jeffrey T Billheimer; George H Rothblat; Alan R Tall; Daniel J Rader
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

View more
  23 in total

Review 1.  Macrophage Plasticity and Function in the Eye and Heart.

Authors:  Zelun Wang; Andrew L Koenig; Kory J Lavine; Rajendra S Apte
Journal:  Trends Immunol       Date:  2019-08-15       Impact factor: 16.687

Review 2.  Transcriptional programming of human macrophages: on the way to systems immunology.

Authors:  Joachim L Schultze
Journal:  J Mol Med (Berl)       Date:  2015-04-16       Impact factor: 4.599

3.  Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration.

Authors:  Norimitsu Ban; Tae Jun Lee; Abdoulaye Sene; Zhenyu Dong; Andrea Santeford; Jonathan B Lin; Daniel S Ory; Rajendra S Apte
Journal:  J Lipid Res       Date:  2018-06-26       Impact factor: 5.922

4.  FGF2-induced STAT3 activation regulates pathologic neovascularization.

Authors:  Zhenyu Dong; Andrea Santeford; Norimitsu Ban; Tae Jun Lee; Craig Smith; David M Ornitz; Rajendra S Apte
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

Review 5.  VEGF in Signaling and Disease: Beyond Discovery and Development.

Authors:  Rajendra S Apte; Daniel S Chen; Napoleone Ferrara
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

Review 6.  Seeing through VEGF: innate and adaptive immunity in pathological angiogenesis in the eye.

Authors:  Abdoulaye Sene; David Chin-Yee; Rajendra S Apte
Journal:  Trends Mol Med       Date:  2014-11-01       Impact factor: 11.951

7.  Innate Immunity in Age-Related Macular Degeneration.

Authors:  Yikui Zhang; Wai T Wong
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  NAMPT-Mediated NAD(+) Biosynthesis Is Essential for Vision In Mice.

Authors:  Jonathan B Lin; Shunsuke Kubota; Norimitsu Ban; Mitsukuni Yoshida; Andrea Santeford; Abdoulaye Sene; Rei Nakamura; Nicole Zapata; Miyuki Kubota; Kazuo Tsubota; Jun Yoshino; Shin-Ichiro Imai; Rajendra S Apte
Journal:  Cell Rep       Date:  2016-09-27       Impact factor: 9.423

9.  Macrophage microRNA-150 promotes pathological angiogenesis as seen in age-related macular degeneration.

Authors:  Jonathan B Lin; Harsh V Moolani; Abdoulaye Sene; Rohini Sidhu; Pamela Kell; Joseph B Lin; Zhenyu Dong; Norimitsu Ban; Daniel S Ory; Rajendra S Apte
Journal:  JCI Insight       Date:  2018-04-05

10.  Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss.

Authors:  Norimitsu Ban; Tae Jun Lee; Abdoulaye Sene; Mayur Choudhary; Michael Lekwuwa; Zhenyu Dong; Andrea Santeford; Jonathan B Lin; Goldis Malek; Daniel S Ory; Rajendra S Apte
Journal:  JCI Insight       Date:  2018-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.